Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma

Clinical trial NCT00075634 · COMPLETED

Trial details

NCT number: NCT00075634
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Neuroblastoma Unspecified Childhood Solid Tumor, Protocol Specific

Start date: 2003-12-01
Primary completion: 2007-09-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.